Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 33.

Lang, B M; Biedermann, L; van Haaften, W T; de Vallière, C; Schuurmans, M; Begré, S; Zeitz, J; Scharl, M; Turina, M; Greuter, T; Schreiner, P; Heinrich, H; Kuntzen, T; Vavricka, S R; Rogler, G; Beerenwinkel, N; Misselwitz, B; Swiss IBD Cohort Study Group (2018). Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohn's disease. Alimentary Pharmacology & Therapeutics, 47(1):55-66.

Safroneeva, E; Vavricka, S R; Fournier, N; Pittet, V; Peyrin-Biroulet, L; Straumann, A; Rogler, G; Schoepfer, A M; Braegger, C; Swiss IBD Cohort Study Group (2015). Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease. Alimentary Pharmacology & Therapeutics, 42(8):977-989.

Biedermann, L; Fournier, N; Misselwitz, B; Frei, P; Zeitz, J; Manser, C N; Pittet, V; Juillerat, P; von Känel, R; Fried, M; Vavricka, S R; Rogler, G (2015). High rates of smoking especially in female Crohn's disease patients and low use of supportive measures to achieve smoking cessation-data from the swiss IBD cohort study. Journal of Crohn's & colitis, 9(10):819-829.

Rogler, G; Vavricka, S R; Biedermann, L (2015). Integrating imaging into clinical practice in inflammatory bowel disease. Digestive Diseases, 33 Suppl:37-43.

Spalinger, M R; Kasper, S; Chassard, C; Raselli, T; Frey-Wagner, I; Gottier, C; Lang, S; Atrott, K; Vavricka, S R; Mair, F; Becher, B; Lacroix, C; Fried, M; Rogler, G; Scharl, M (2015). PTPN2 controls differentiation of CD4(+) T cells and limits intestinal inflammation and intestinal dysbiosis. Mucosal immunology, 8(4):918-929.

Barthel, C; Wiegand, S; Scharl, S; Scharl, M; Frei, P; Vavricka, S R; Fried, M; Sulz, M C; Wiegand, N; Rogler, G; Biedermann, L (2015). Patients' perceptions on the impact of coffee consumption in inflammatory bowel disease: friend or foe?--a patient survey. Nutrition Journal, 14:78.

Zeitz, J; Vavricka, S R (2013). Therapie der extraintestinalen CED-Manifestationen : Eine schwierige Herausforderung. Der Gastroenterologe, 8(3):217-225.

Misselwitz, B; Pohl, D; Fruhauf, H; Fried, M; Vavricka, S R; Fox, Mark (2013). Lactose malabsorption and intolerance: pathogenesis, diagnosis and treatment. United European Gastroenterology journal, 1(3):151-159.

Hammann, F; Hruz, P; Kullak-Ublick, G A; Vavricka, S R; Beglinger, C; Drewe, J; Gutmann, H (2012). Determination of the Single Nucleotide Polymorphisms C3435 and G2677T in MDR1 and C421A in BCRP in blood samples of patients with inflammatory bowel disease and healthy controls in the swiss population. Metabolomics, 2:104.

Scharl, M; Wojtal, K A; Becker, H M; Fischbeck, A; Frei, P; Arikkat, J; Pesch, T; Kellermeier, S; Boone, D L; Weber, A; Loessner, M J; Vavricka, S R; Fried, M; McCole, D F; Rogler, G (2012). Protein tyrosine phosphatase nonreceptor type 2 regulates autophagosome formation in human intestinal cells. Inflammatory Bowel Diseases, 18(7):1287-1302.

Vavricka, S R; Bentele, N; Scharl, M; Rogler, G; Zeitz, J; Frei, P; Straumann, A; Binek, J; Schoepfer, A M; Fried, M (2012). Systematic assessment of factors influencing preferences of crohn's disease patients in selecting an anti-tumor necrosis factor agent (CHOOSE TNF TRIAL). Inflammatory Bowel Diseases, 18(8):1523-1530.

Vavricka, S R; Spigaglia, S M; Rogler, G; Pittet, V; Michetti, P; Felley, C; Mottet, C; Braegger, C P; Rogler, D; Straumann, A; Bauerfeind, P; Fried, M; Schoepfer, A M (2011). Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease. Inflammatory Bowel Diseases, 18(3):496-505.

Scharl, M; Frei, P; Fried, M; Rogler, G; Vavricka, S R (2011). Association between Cogan's syndrome and inflammatory bowel disease: a case series. Journal of Crohn's and Colitis, 5(1):64-68.

Eloranta, J J; Wenger, C; Mwinyi, J; Hiller, C; Gubler, C; Vavricka, S R; Fried, M; Kullak-Ublick, G A (2011). Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease. Pharmacogenetics and Genomics, 21(9):559-564.

Scharl, M; Geisel, S; Vavricka, S R; Rogler, G (2011). Dying in yoghurt: the number of living bacteria in probiotic yoghurt decreases under exposure to room temperature. Digestion, 83(1-2):13-17.

Vavricka, S R; Schoepfer, A M; Bansky, G; Binek, J; Felley, C; Geyer, M; Manz, M; Rogler, G; de Saussure, P; Sauter, B; Scharl, M; Seibold, F; Straumann, A; Michetti, P (2011). Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey. Inflammatory Bowel Diseases, 17(7):1530-1539.

Braegger, C P; Ballabeni, P; Rogler, D; Vavricka, S R; Friedt, M; Pittet, V (2011). Epidemiology of inflammatory bowel disease: Is there a shift towards onset at a younger age? Journal of Pediatric Gastroenterology and Nutrition, 53(2):141-144.

Vavricka, S R; Brun, L; Ballabeni, P; Pittet, V; Prinz Vavricka, B M; Zeitz, J; Rogler, G; Schoepfer, A M (2011). Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. American Journal of Gastroenterology, 106(1):110-119.

Scharl, M; McCole, D F; Weber, A; Vavricka, S R; Frei, P; Kellermeier, S; Pesch, T; Fried, M; Rogler, G (2011). Protein tyrosine phosphatase N2 regulates TNFα-induced signalling and cytokine secretion in human intestinal epithelial cells. Gut, 60(2):189-197.

Heinrich, H; Goetze, O; Menne, D; Iten, P X; Fruehauf, H; Vavricka, S R; Schwizer, W; Fried, M; Fox, M (2010). Effect on gastric function and symptoms of drinking wine, black tea, or schnapps with a Swiss cheese fondue: randomised controlled crossover trial. BMJ : British medical journal, 341:c6731.

Schoepfer, A M; Vavricka, S R; Binek, J; Felley, C; Geyer, M; Manz, M; Rogler, G; de Saussure, P; Sauter, B; Seibold, F; Straumann, A; Michetti, P (2010). Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: Results of the FACTS survey. Inflammatory Bowel Diseases, 16(6):933-938.

Vavricka, S R; Tutuian, R; Imhof, A; Wildi, S; Gubler, C; Fruehauf, H; Ruef, C; Schoepfer, A M; Fried, M (2010). Air suctioning during colon biopsy forceps removal reduces bacterial air contamination in the endoscopy suite. Endoscopy, 42(9):736-741.

Schoepfer, A M; Beglinger, C; Straumann, A; Trummler, M; Vavricka, S R; Bruegger, L E; Seibold, F (2010). Fecal calprotectin correlates more closely with the simple endoscopic score for Crohn's Disease (SES-CD) than CRP, blood leukocytes, and the CDAI. American Journal of Gastroenterology, 105(1):162-169.

Vavricka, S R; Rogler, G (2010). Fistula treatment: The unresolved challenge. Digestive Diseases, 28(3):556-564.

Voegtlin, M; Vavricka, S R; Schoepfer, A M; Straumann, A; Voegtlin, J; Rogler, G; Ballabeni, P; Pittet, V; Buser, A; Fried, M; Beglinger, C (2010). Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals. Journal of Crohn's and Colitis, 4(6):642-648.

Vavricka, S R; Rogler, G (2010). Recent advances in the etiology and treatment of Crohn's disease. Minerva Gastroenterologica e Dietologica, 56(2):203-211.

Vavricka, S R; Rogler, G (2009). Treatment of severe ulcerative colitis: differences in elderly patients? Digestive Diseases, 27(3):315-321.

Wojtal, K A; Eloranta, J J; Hruz, P; Gutmann, H; Drewe, J; Beglinger, C; Fried, M; Kullak-Ublick, G A; Vavricka, S R (2009). Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients. Drug Metabolism and Disposition, 37(9):1871-1877.

Lee, J; Tattoli, I; Wojtal, K A; Vavricka, S R; Philpott, D J; Girardin, S E (2009). pH-dependent Internalization of Muramyl Peptides from Early Endosomes Enables Nod1 and Nod2 Signaling. Journal of Biological Chemistry, 284(35):23818-23829.

Manz, M; Beglinger, C; Vavricka, S R (2009). Fatal invasive pulmonary aspergillosis associated with adalimumab therapy. Gut, 58(1):149.

Zeitz, J; Mullhaupt, B; Fruehauf, H; Rogler, G; Vavricka, S R (2009). Hepatic failure due to hepatitis B reactivation in a patient with ulcerative colitis treated with prednisone. Hepatology, 50(2):653-654.

Vavricka, S R; Rogler, G (2009). Therapie der Colitis ulcerosa. Praxis, 98(4):209-212.

Hochholzer, W; Vavricka, S R; Stussi, G; Adams, H; Wruk, D; Battegay, E; Zimmerli, L U (2008). Diffuse Bauchschmerzen und Eosinophilie. Der Internist, 49(11):1379-1382.

This list was generated on Wed Dec 12 21:40:32 2018 CET.